Eryan Yang

618 total citations
12 papers, 431 citations indexed

About

Eryan Yang is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Eryan Yang has authored 12 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Epidemiology and 4 papers in Cancer Research. Recurrent topics in Eryan Yang's work include Acute Ischemic Stroke Management (3 papers), Cancer-related molecular mechanisms research (3 papers) and Barrier Structure and Function Studies (2 papers). Eryan Yang is often cited by papers focused on Acute Ischemic Stroke Management (3 papers), Cancer-related molecular mechanisms research (3 papers) and Barrier Structure and Function Studies (2 papers). Eryan Yang collaborates with scholars based in China and Portugal. Eryan Yang's co-authors include Chunsheng Kang, Qixue Wang, Yunfei Wang, Kaikai Yi, Ying Cai, Xiuhua Yao, Weijia Fan, Xuebin Zhang, Jialing Wu and Ji Liu and has published in prestigious journals such as Frontiers in Immunology, Cancer Letters and Cell Death and Disease.

In The Last Decade

Eryan Yang

11 papers receiving 428 citations

Peers

Eryan Yang

EPIDE

NEURO

PRM

Zhuanghui Wang China

Kangyi Yue China

Han Xiao China

Xiang Sun China

Xiyang Yao China

Shuwen Shen China

Olivia Singh Canada

Min Chao China

Zhangqi Dou China

Zhe Huang Japan

Zhuanghui Wang China

Eryan Yang

413 ×1.6

144 ×1.0

90 ×0.8

EPIDE

61 ×0.7

NEURO

81 ×2.0

PRM

Citations per year, relative to Eryan Yang Eryan Yang (= 1×) peers Zhuanghui Wang

Countries citing papers authored by Eryan Yang

Since Specialization

Citations

This map shows the geographic impact of Eryan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eryan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eryan Yang more than expected).

Fields of papers citing papers by Eryan Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eryan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eryan Yang. The network helps show where Eryan Yang may publish in the future.

Co-authorship network of co-authors of Eryan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Eryan Yang. A scholar is included among the top collaborators of Eryan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eryan Yang. Eryan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Zheng, Xingyu, Eryan Yang, Ye Yan, et al.. (2025). AQB improves carboplatin sensitivity in endometrial cancer through dual DNA repair modulation: suppression of the p21-E2F1-RAD51 and ATF3-HDAC1-BRCA1 signaling. Cell Death and Disease. 17(1). 70–70.

Zhao, Shuangshuang, Ye Yan, Jingying Zhang, et al.. (2025). The Value of Integrating Hormone Receptors into Immunohistochemistry-Based Simplified Molecular Classification in Endometrial Cancer. Cancer Management and Research. Volume 17. 869–880. 1 indexed citations

Yang, Eryan, Biao Hong, Yunfei Wang, et al.. (2024). EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma. Cancer Letters. 588. 216812–216812. 10 indexed citations

Hong, Biao, Eryan Yang, Xiaoteng Cui, et al.. (2023). EPIC-1042 as a potent PTRF/Cavin1–caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma. Neuro-Oncology. 26(1). 100–114. 10 indexed citations

Yang, Eryan, Lin Wang, Weili Jin, et al.. (2022). PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma. Theranostics. 12(9). 4330–4347. 27 indexed citations

Yi, Kaikai, Xiaoteng Cui, Xing Liu, et al.. (2022). PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma. Frontiers in Immunology. 12. 802795–802795. 26 indexed citations

Jin, Weili, Jixing Zhao, Eryan Yang, et al.. (2022). Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A. Theranostics. 12(7). 3196–3216. 61 indexed citations

Zhao, Jixing, Shixue Yang, Xiaoteng Cui, et al.. (2022). A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma. Neuro-Oncology. 25(5). 857–870. 43 indexed citations

Jin, Weili, Ye Wu, Ning Chen, et al.. (2021). Early administration of MPC-n(IVIg) selectively accumulates in ischemic areas to protect inflammation-induced brain damage from ischemic stroke. Theranostics. 11(17). 8197–8217. 17 indexed citations

10.

Yi, Kaikai, Xueping Li, Xiaoteng Cui, et al.. (2021). Phosphatidylcholine‐Engineered Exosomes for Enhanced Tumor Cell Uptake and Intracellular Antitumor Drug Delivery. Macromolecular Bioscience. 21(8). e2100042–e2100042. 50 indexed citations

11.

Cai, Ying, Eryan Yang, Xiuhua Yao, et al.. (2020). FUNDC1-dependent mitophagy induced by tPA protects neurons against cerebral ischemia-reperfusion injury. Redox Biology. 38. 101792–101792. 163 indexed citations

12.

Yang, Eryan, Ying Cai, Xiuhua Yao, et al.. (2019). Tissue plasminogen activator disrupts the blood-brain barrier through increasing the inflammatory response mediated by pericytes after cerebral ischemia. Aging. 11(22). 10167–10182. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact